Loading clinical trials...
Loading clinical trials...
The immune mechanism of the nucleos(t)ide analogs (NAs) in inhibiting HBV replication effectively while having a low sustained virus control rate after drug withdrawal is unclear. B cell immunity and ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Changhai Hospital
NCT06990438 · Tenofovir Disoproxil Fumarate, Bone Density, and more
NCT02836236 · HBV, Chronic HBV Infection
NCT05851261 · Chronic HBV Infection
NCT05542979 · Chronic HBV Infection
NCT02952846 · Drug Withdrawal Symptoms, Critical Care, and more
Changhai hospital
Shanghai
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions